Literature DB >> 16921688

Effects of conventional ultrafiltration on renal performance during adult cardiopulmonary bypass procedures.

Rick A Kuntz1, David W Holt, Scott Turner, Lee Stichka, Bryan Thacker.   

Abstract

Ultrafiltration has been used successfully in a variety of applications in the perioperative setting to assist in hemoconcentration and volume reduction. This study was designed to investigate the effects of aggressive conventional hemofiltration on bypass urine production, fluid balance, and renal performance in the 24 hours after bypass procedures in the adult population. A prospective, randomized study was designed to determine the effects of conventional ultrafiltration (CUF) during bypass while monitoring urine dynamics intraoperatively and in the 24-hour post-bypass period. Study group 1 (CUF, n = 49) was compared to control group 2 (non-CUF, n = 47) by monitoring urine values, volume additions, and packed red cell (PRC) use throughout the procedure. The mean total CUF volume removed from group 1 was 5781 +/- 2612. There were no differences in pre-bypass, total bypass, or total operating room (OR) urine between the two groups. The 24-hour urine totals were significantly higher in group 2 (2389 +/- 895) than in group 1 (2035 +/- 895). The ending bypass hematocrit was also lower in group 2 (26 +/- 2.0) than in group 1 (30 +/- 6.0). OR PRC additions were higher in group 2 (395 +/- 699) than group 1 (204 +/- 300). The non-CUF control group 2 experienced significantly greater ending fluid balance (3006 +/- 868) compared with group 1 (744 +/- 1271). No significant differences in pre- or postoperative creatinine values were observed. Aggressive CUF can be safely used during cardiopulmonary bypass in the adult population to reduce fluid accumulation and elevate bypass hematocrit without effecting bypass or intraoperative urine production.

Entities:  

Mesh:

Year:  2006        PMID: 16921688      PMCID: PMC4680751     

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


  65 in total

Review 1.  Aprotinin and the systemic inflammatory response after cardiopulmonary bypass.

Authors:  C F Mojcik; J H Levy
Journal:  Ann Thorac Surg       Date:  2001-02       Impact factor: 4.330

2.  Clinical experience with the mini-extracorporeal circulation system: an evolution or a revolution?

Authors:  Jean-Paul Remadi; Paul Marticho; Irina Butoi; Zava Rakotoarivelo; Faouzi Trojette; Amar Benamar; Sadek Beloucif; Dominique Foure; Henri J Poulain
Journal:  Ann Thorac Surg       Date:  2004-06       Impact factor: 4.330

3.  Does modified ultrafiltration reduce the systemic inflammatory response to cardiac surgery with cardiopulmonary bypass?

Authors:  Michelle S Chew
Journal:  Perfusion       Date:  2004       Impact factor: 1.972

4.  Incidence, prevention, and treatment of acute renal failure following cardiopulmonary bypass.

Authors:  A Krian
Journal:  Int Anesthesiol Clin       Date:  1976

5.  A combined approach for improving cardiopulmonary bypass in coronary artery surgery: a pilot study.

Authors:  Christophe Baufreton; Jean Louis de Brux; Patrice Binuani; Jean-Jacques Corbeau; Jean Baptiste Subayi; Jean Claude Daniel; Patrick Treanor
Journal:  Perfusion       Date:  2002-11       Impact factor: 1.972

6.  Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group.

Authors:  G R DeFoe; C S Ross; E M Olmstead; S D Surgenor; M P Fillinger; R C Groom; R J Forest; J W Pieroni; C S Warren; M E Bogosian; C F Krumholz; C Clark; R A Clough; P W Weldner; S J Lahey; B J Leavitt; C A Marrin; D C Charlesworth; P Marshall; G T O'Connor
Journal:  Ann Thorac Surg       Date:  2001-03       Impact factor: 4.330

7.  Modified ultrafiltration attenuates dilutional coagulopathy in pediatric open heart operations.

Authors:  R H Friesen; D N Campbell; D R Clarke; M A Tornabene
Journal:  Ann Thorac Surg       Date:  1997-12       Impact factor: 4.330

8.  Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery.

Authors:  K Karkouti; W S Beattie; D N Wijeysundera; V Rao; C Chan; K M Dattilo; G Djaiani; J Ivanov; J Karski; T E David
Journal:  J Thorac Cardiovasc Surg       Date:  2005-02       Impact factor: 5.209

9.  The benefits of continuous ultrafiltration in pediatric cardiac surgery.

Authors:  Kenan Sever; Turkan Tansel; Murat Basaran; Eylul Kafali; Murat Ugurlucan; Omer Ali Sayin; Ufuk Alpagut; Enver Dayioglu; Ertan Onursal
Journal:  Scand Cardiovasc J       Date:  2004-10       Impact factor: 1.589

Review 10.  Predictive performance of ten equations for estimating creatinine clearance in cardiac patients. Iohexol Cooperative Study Group.

Authors:  S A Spinler; J J Nawarskas; E G Boyce; J E Connors; S L Charland; S Goldfarb
Journal:  Ann Pharmacother       Date:  1998-12       Impact factor: 3.154

View more
  4 in total

1.  Acute Kidney Injury After Pediatric Cardiac Surgery: A Secondary Analysis of the Safe Pediatric Euglycemia After Cardiac Surgery Trial.

Authors:  Joshua J Blinder; Lisa A Asaro; David Wypij; David T Selewski; Michael S D Agus; Michael Gaies; Michael A Ferguson
Journal:  Pediatr Crit Care Med       Date:  2017-07       Impact factor: 3.624

2.  Zero-Balance Ultrafiltration during Cardiopulmonary Bypass Is Associated with Decreased Urine Output.

Authors:  Alfred H Stammers; Eric A Tesdahl; Linda B Mongero; Kirti P Patel; Courtney C Petersen; Jennifer Arriola Vucovich; Jeffrey P Jacobs
Journal:  J Extra Corpor Technol       Date:  2021-03

3.  Ultrafiltration and cardiopulmonary bypass associated acute kidney injury: A systematic review and meta-analysis.

Authors:  Omneya A Kandil; Karam R Motawea; Edward Darling; Jeffrey B Riley; Jaffer Shah; Mohamed Abdalla Mohamed Elashhat; Bruce Searles; Hani Aiash
Journal:  Clin Cardiol       Date:  2021-11-27       Impact factor: 2.882

4.  The outcomes of ultrafiltration in on-pump versus off-pump coronary artery bypass grafting in patients with renal impairment.

Authors:  Amarit Phothikun; Weerachai Nawarawong; Apichat Tantraworasin; Thitipong Tepsuwan
Journal:  J Cardiothorac Surg       Date:  2022-08-31       Impact factor: 1.522

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.